There is a body of evidence indicating that TSLP can activate DCs and mast cells, leading to the induction of Th2-type immune responses, and it is increasingly suggested that TSLP may be considered an important molecular player in the pathophysiology of AD. This evidence concerns the gene TSLP and Alzheimer disease.